Glycaemic control in end-of-life care: fundamental or futile?

Magnus Lindskog; Lars Kärvestedt; Carl Johan Fürst

doi:10.1097/SPC.0000000000000095

Glycaemic control in end-of-life care: fundamental or futile?

Magnus Lindskog, Lars Kärvestedt, Carl Johan Fürst

Breastcancer-genetics

Research output: Contribution to journal › Review article › peer-review

Abstract

Diabetes mellitus is one of the most common comorbidities in palliative care. Yet, the optimal handling of diabetes mellitus in dying patients is debated. This review aims to discuss comprehensively the scientific basis as of today for diabetes mellitus management decisions in end-of-life (EOL) care.

Original language	English
Pages (from-to)	378-382
Journal	Current Opinion in Supportive and Palliative Care
Volume	8
Issue number	4
DOIs	https://doi.org/10.1097/SPC.0000000000000095
Publication status	Published - 2014

Subject classification (UKÄ)

Cancer and Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/SPC.0000000000000095

http://www.ncbi.nlm.nih.gov/pubmed/25259543?dopt=Abstract

Cite this

@article{09dba653de54401298660e6f66c8bd19,

title = "Glycaemic control in end-of-life care: fundamental or futile?",

abstract = "Diabetes mellitus is one of the most common comorbidities in palliative care. Yet, the optimal handling of diabetes mellitus in dying patients is debated. This review aims to discuss comprehensively the scientific basis as of today for diabetes mellitus management decisions in end-of-life (EOL) care.",

author = "Magnus Lindskog and Lars K{\"a}rvestedt and F{\"u}rst, {Carl Johan}",

year = "2014",

doi = "10.1097/SPC.0000000000000095",

language = "English",

volume = "8",

pages = "378--382",

journal = "Current Opinion in Supportive and Palliative Care",

issn = "1751-4266",